Signals of gastroesophageal reflux disease caused by incretin-based drugs: a disproportionality analysis using the Japanese adverse drug event report database

Signals of gastroesophageal reflux disease caused by incretin-based drugs: a disproportionality analysis using the Japanese adverse drug event report database

Abstract Background Incretin-based drugs are important in the treatment of type 2 diabetes. However, among the incretin-based drugs, glucagon-like peptide-1 receptor agonists (GLP-1-RAs) have been reported to cause gastroesophageal reflux disease (GERD)-like symptoms making it difficult to continue...

Full description

Bibliographic Details
Main Authors: Yoshihiro Noguchi, Hayato Katsuno, Anri Ueno, Manami Otsubo, Aki Yoshida, Yuta Kanematsu, Ikuto Sugita, Hiroki Esaki, Tomoya Tachi, Teruo Tsuchiya, Hitomi Teramachi
Format: Article
Language:English
Published: BMC 2018-06-01
Series:Journal of Pharmaceutical Health Care and Sciences
Subjects:
Disproportionality analysis
Incretin-based drugs
Glucagon-like peptide-1 receptor agonists
DPP-4 inhibitors
Gastroesophageal reflux disease
Japanese adverse drug event report database
Online Access:http://link.springer.com/article/10.1186/s40780-018-0109-z

Similar Items

Similar Items